Effects of growth hormone on kidney function in pediatric transplant recipients

Blanche M Chavers, Leah Doherty, Thomas E Nevins, Marie Cook, Kumud Sane

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Recent evidence suggests that treatment with recombinant human growth hormone (rhGH) after a successful kidney transplant improves the growth rate of children with short stature. We prospectively investigated eight children (6 boys, 2 girls), focusing on acute rejection episodes and changes in serum creatinine levels during rhGH treatment. The children (mean age 11.6±3.4 years) received rhGH daily (0.04-0.05 mg/kg subcutaneously). Seven patients completed at least 12 months (20±8 months) of rhGH treatment. Their mean serum creatinine level was 1.3±0.7 mg/dl 12 months before, and increased to 3.4±4.2 mg/dl after 12 months of rhGH treatment, but did not achieve statistical significance (P=0.06). Their mean calculated glomerular filtration rate was 58±20 ml/min per 1.73 m2 12 months before, and decreased to 38±21 ml/min per 1.73 m2 12 months before, and decreased to 38±21 ml/min per 1.73 m2 after 12 months of rhGH treatment, but did not achieve statistical significance (P=0.08). Of the seven patients, two developed acute rejection after 5 and 6 rejection-free years; three lost their grafts and returned to dialysis. These preliminary observations describe untoward renal events in children receiving rhGH treatment after a kidney transplant.

Original languageEnglish (US)
Pages (from-to)176-181
Number of pages6
JournalPediatric Nephrology
Volume9
Issue number2
DOIs
StatePublished - Apr 1995

Keywords

  • Kidney transplantation
  • Recombinant human growth hormone
  • Rejection

Fingerprint Dive into the research topics of 'Effects of growth hormone on kidney function in pediatric transplant recipients'. Together they form a unique fingerprint.

Cite this